The global Rx medical food market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is expected to fuel the global Rx medical food market during the forecast period includes increasing regulatory support and awareness about medical food among healthcare professionals. Moreover, the other factors that will augment the market growth include major investments by key players such as Nestlé and Danone in the R&D of medical foods, along with a widening scope across applications such as chronic pain, and personalized medicine. Rx medical food currently available in the market includes Axona (Accera), Limbrel, Deplin, Lofenalac, Ensure, Vasculera, and Vascazen. Medical food is a category of food products for dietary management or preventive therapy for a specific disease or medical conditions such as pulmonary, gastrointestinal, and metabolic disorders. Ingredients used in medical foods must have generally recognized as safe (GRAS) status. Medical food is different from nutritional food, dietary supplements, as well as from prescription drugs. Medical food is protein-based, nutrient-based (Omega 3 fatty acids, chelated zinc, and isoflavones), and may contain minerals and vitamins such as folic acid and thiamine. 

These products are prescribed by physicians or taken under their supervision. Medical foods are classified by the US Food & Drug Administration (FDA), into four major categories; nutritionally complete products, nutritionally incomplete products, formulas for metabolic disorders, and oral rehydration solutions. The US FDA separately regulates medical food under Orphan Drug Act (1988) to ensure the safety of the populace and curb the presence of products falsely claiming to cure medical conditions. Medical food does not require premarket approval, specification as an investigational new drug (IND), and individual registration with the FDA. However, they are required to support all their health claims with proper laboratory and clinical studies. The major factors that are restraining the growth of the global Rx medical food market include side effects and complications caused by Rx medical food products if they are consumed in excess amounts.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Abbott Laboratories, Danone S.A., and Nestlé S.A., among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Rx Medical Food Market Report by Segment

By Type 

• Pills

• Powder

• Liquid 

• Others

By Application 

• Pain Management

• Neurological Disorder

• GI Disorder

• Pulmonary Disorders

• Metabolic Disorders 

• Others

Global Rx Medical Food Market by Region